Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23668 ↗At a glance
Journal article in Molecular Carcinogenesis, 2024. Written by Keping Deng and 4 co-authors. Institution: Department of General Surgery, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South Universi…. Major MEDLINE topics: Cancer-Associated Fibroblasts, MicroRNAs, Pancreatic Neoplasms. Cited 27 times so far (Crossref); 48 references. Funded by: General guidance project of Hunan Provincial Health Commission.
Abstract (original language)
Gemcitabine (GEM) resistance affects chemotherapy efficacy of pancreatic cancer (PC). Cancer‐associated fibroblasts (CAFs) possess the ability of regulating chemoresistance. This study probed the mechanism of hypoxia‐treated CAFs regulating cell stemness and GEM resistance in PC. Miapaca‐2/SW1990 were co‐cultured with PC‐derived CAFs under normoxic/hypoxic conditions. Cell viability/self‐renewal ability was determined by MTT/sphere formation assays, respectively. Protein levels of CD44, CD133, Oct4, and Sox2 were determined by western blot. GEM tumoricidal assay was performed. PC cell GEM resistance was evaluated by MTT assay. CAFs were cultured at normoxia/hypoxia. HIF‐1α and miR‐21 expression levels were assessed by RT‐qPCR and western blot, with their binding sites and binding relationship predicted and verified. CAF‐extracellular vesicles (EVs) were incubated with Miapaca‐2 cells. The RAS/AKT/ERK pathway activation was detected by western blot. PC xenograft models were established and treated with hypoxic CAF‐EVs and GEM. CAFs and PC cell co‐culture increased cell stemness maintenance, GEM resistance, cell viability, stem cell sphere number, and protein levels of CD44, CD133, Oct4, and Sox2, and weakened GEM tumoricidal ability to PC cells, with the effects further enhanced by hypoxia. Hypoxia induced HIF‐1α and miR‐21 overexpression in CAFs. Hypoxia promoted CAFs to secrete high‐level miR‐21 EVs via the HIF‐1α/miR‐21 axis, and activated the miR‐21/RAS/AKT/ERK pathway. CAF‐EVs promoted GEM resistance in PC via the miR‐21/RAS/ATK/ERK pathway in vivo. Hypoxia promoted CAFs to secrete high‐level miR‐21 EVs through the HIF‐1α/miR‐21 axis, and activated the miR‐21/RAS/AKT/ERK pathway via EVs to trigger stemness maintenance and GEM resistance in PC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of General Surgery, The First Hospital of Changsha (The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University), Changsha, Hunan Province, China.
ORCID profiles: Zhen Luo
Funding
- General guidance project of Hunan Provincial Health Commission
Cite
APA
Deng, K., Zou, F., Xu, J., Xu, D., & Luo, Z. (2024). Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23668
Vancouver
Deng K, Zou F, Xu J, Xu D, Luo Z. Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23668
BibTeX
@article{Deng2024,
author = {Deng, Keping and Zou, Fang and Xu, Jin and Xu, Dayong and Luo, Zhen},
title = {Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23668}
}
EUVIMED